Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-15 7:20 pm Unchanged |
2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Asset Management Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-09-30 09:00 am Purchase |
2024-09-26 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT, LLC | 2,407,800 6.600% |
2,407,800 (New Position) |
Filing History |
| 2024-05-15 08:37 am Purchase |
2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 2,946,915 8.100% |
792,857 (+36.81%) |
Filing History |
| 2024-05-14 9:10 pm Sale |
2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS |
RA CAPITAL MANAGEMENT L.P. | 3,659,046 9.990% |
-758,213 (-17.16%) |
Filing History |
| 2024-02-16 12:54 pm Purchase |
2024-02-05 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital, LLC | 1,944,672 5.400% |
1,944,672 (New Position) |
Filing History |
| 2024-02-14 09:45 am Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.500% |
-551,359 (-30.45%) |
Filing History |
| 2024-02-13 5:08 pm Sale |
2023-12-29 | 13G | iTeos Therapeutics, Inc. ITOS |
The Vanguard Group | 1,490,942 4.170% |
-328,088 (-18.04%) |
Filing History |
| 2024-01-23 4:13 pm Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,261,745 11.900% |
-217,676 (-4.86%) |
Filing History |
| 2024-01-09 4:26 pm Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
Millennium Management LLC | 967,402 2.700% |
-1,123,431 (-53.73%) |
Filing History |
| 2023-10-24 4:12 pm Purchase |
2023-10-17 | 13G | iTeos Therapeutics, Inc. ITOS |
Millennium Management LLC | 2,090,833 5.800% |
2,090,833 (New Position) |
Filing History |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 0 0.000% |
-2,353,015 (Position Closed) |
Filing History |
| 2023-02-13 6:14 pm Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.100% |
-118,366 (-6.14%) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | iTeos Therapeutics, Inc. ITOS |
The Vanguard Group | 1,819,030 5.110% |
1,819,030 (New Position) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,479,421 12.600% |
0 (Unchanged) |
Filing History |
| 2023-01-20 5:17 pm Purchase |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
4,479,421 12.600% |
758,184 (+20.37%) |
Filing History |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Inc. BLK |
3,721,237 10.500% |
3,721,237 (New Position) |
Filing History |
| 2022-05-11 5:14 pm Sale |
2022-05-09 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 2,154,058 6.100% |
-988,000 (-31.44%) |
Filing History |
| 2022-05-02 5:02 pm Purchase |
2022-04-22 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.400% |
1,929,201 (New Position) |
Filing History |
| 2022-03-18 9:00 pm Sale |
2022-03-17 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,142,058 8.900% |
-575,201 (-15.47%) |
Filing History |
| 2022-02-14 08:41 am Sale |
2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 2,353,015 6.700% |
-409,776 (-14.83%) |
Filing History |